Aflac (AFL) to Release Earnings on Tuesday

Key Points

• Aflac (NYSE:AFL) is set to release its Q2 2025 earnings report on August 5th, with analysts expecting earnings of $1.73 per share and revenue of $4.30 billion.
$1.66, falling short of the $1.67 consensus estimate, with revenues significantly down 37.5% year-over-year.
• The company's recent quarterly dividend of $0.58 reflects a yield of 2.30%, with an annualized payout ratio of 36.25%.

Aflac (NYSE:AFL - Get Free Report) is anticipated to announce its Q2 2025 earnings results after the market closes on Tuesday, August 5th. Analysts expect Aflac to post earnings of $1.73 per share and revenue of $4.30 billion for the quarter.

Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The firm had revenue of $3.40 billion during the quarter, compared to the consensus estimate of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. The business's quarterly revenue was down 37.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.66 EPS. On average, analysts expect Aflac to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Aflac Trading Down 1.7%

Aflac stock traded down $1.69 during trading hours on Friday, reaching $97.67. The company had a trading volume of 847,780 shares, compared to its average volume of 2,120,622. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09. Aflac has a 12-month low of $95.97 and a 12-month high of $115.50. The firm has a market cap of $52.81 billion, a price-to-earnings ratio of 15.26, a P/E/G ratio of 3.05 and a beta of 0.81. The company has a 50-day moving average price of $102.67 and a 200 day moving average price of $105.09.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on AFL. Raymond James Financial dropped their target price on Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a report on Thursday, May 29th. Wells Fargo & Company upped their target price on Aflac from $103.00 to $105.00 and gave the stock an "equal weight" rating in a report on Thursday, July 10th. Morgan Stanley boosted their price target on Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Monday, May 19th. Barclays set a $98.00 price target on Aflac and gave the company an "underweight" rating in a research note on Monday, July 7th. Finally, JPMorgan Chase & Co. increased their price target on Aflac from $96.00 to $100.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 8th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $108.15.

Insiders Place Their Bets

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the company's stock in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total transaction of $106,790.00. Following the sale, the director owned 26,096 shares of the company's stock, valued at approximately $2,786,791.84. This represents a 3.69% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Arthur Reginald Collins sold 2,750 shares of the stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the completion of the transaction, the director directly owned 6,728 shares in the company, valued at $711,149.60. The trade was a 29.01% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 40,750 shares of company stock worth $4,304,295. 0.90% of the stock is currently owned by company insiders.

Institutional Trading of Aflac

An institutional investor recently raised its position in Aflac stock. Bison Wealth LLC increased its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 4.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,402 shares of the financial services provider's stock after acquiring an additional 183 shares during the quarter. Bison Wealth LLC's holdings in Aflac were worth $455,000 at the end of the most recent reporting period. 67.44% of the stock is currently owned by institutional investors.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.